Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
Optimi Health Corp
NASDAQ:OPTH
|
CA |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
US |
|
Z
|
Zhongce Rubber Group Co Ltd
SSE:603049
|
CN |
|
Civista Bancshares Inc
NASDAQ:CIVB
|
US |
|
R
|
Royal Road Minerals Ltd
OTC:RRDMF
|
JE |
|
B
|
Bbia Co Ltd
KOSDAQ:451250
|
KR |
|
Arrow Exploration Corp
OTC:CSTPF
|
CA |
|
Kelly Services Inc
NASDAQ:KELYA
|
US |
|
G
|
G2 Energy Corp
CNSX:GTOO
|
CA |
|
K
|
Keyera Corp
F:K2Y
|
CA |
|
C
|
Citra Nusantara Gemilang Tbk PT
IDX:CGAS
|
ID |
|
Nerds On Site Inc
F:3NS
|
CA |
|
N
|
Nestle Pakistan Ltd
KAR:NESTLE
|
PK |
|
S
|
Suprema Inc
KOSDAQ:236200
|
KR |
|
Torex Gold Resources Inc
F:73GN
|
CA |
|
Marygold Companies Inc
F:TF8
|
US |
Bankruptcy Probability
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lineage Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
240.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
503.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
190.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
98.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lineage Cell Therapeutics Inc has total debt of 15k USD. This includes both short-term (0 USD) and long-term (15k USD) debt.
You can find a full breakdown on its Balance Sheet.